Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.
Analyst Outlook | Price targets range from $14 to $23, with an average of $19.14, as experts weigh Owens & Minor's growth potential against increased leverage and market pressures |
Market Dynamics | Explore how emerging trends like GLP-1 drugs and potential Chinese tariffs could reshape Owens & Minor's competitive landscape in healthcare distribution |
Financial Flux | Mixed Q3 results and lowered guidance reflect challenges in profitability, while CFO transition sparks debates about the company's financial management |
Strategic Expansion | Owens & Minor's $1.36B Rotech acquisition aims to boost its presence in the lucrative Patient Direct business, promising growth but raising integration concerns |

Metrics to compare | ACH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.3x | 10.0x | −0.5x | |
PEG Ratio | 0.01 | 2.25 | 0.00 | |
Price / Book | −0.5x | 2.6x | 2.6x | |
Price / LTM Sales | 0.1x | 0.9x | 3.2x | |
Upside (Analyst Target) | −4.8% | −26.7% | 47.6% | |
Fair Value Upside | Unlock | 30.4% | 6.1% | Unlock |